Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS Open To ASPs For Radiopharmaceuticals; Congress Blocks Rate Cap

Executive Summary

CMS is willing to consider switching Medicare Part B payment for radiopharmaceuticals to the average sales price formula, the agency says in proposed rules to update Medicare's hospital outpatient prospective payment system for 2009

You may also be interested in...



ASP-based Reimbursement For Radiopharmaceuticals Gets PhRMA Support

The Pharmaceutical Research and Manufacturers of America expressed support for using an average sales price-based approach to reimbursing radiopharmaceuticals under Medicare in response to CMS' statement of its willingness to consider switching from reimbursement based on individual hospitals' claims

ASP-based Reimbursement For Radiopharmaceuticals Gets PhRMA Support

The Pharmaceutical Research and Manufacturers of America expressed support for using an average sales price-based approach to reimbursing radiopharmaceuticals under Medicare in response to CMS' statement of its willingness to consider switching from reimbursement based on individual hospitals' claims

Medicare Bill Strikes Out Again In Senate After Home Run In House

Momentum from a surprising House passage of a slightly modified version of the Sen. Max Baucus-penned Medicare physician payment legislation was not quite enough to carry the bill on a second try in the Senate on June 26

Latest Headlines
See All
UsernamePublicRestriction

Register

PS049855

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel